Slide 1: Evolving stronger, growing together
Evolving stronger, growing together Analyst presentation Q1 2025 trading update 25 April 2025
Slide 2: Presenting team
Presenting team Marcus Jordan Hans Kooijmans CEO CFO 2
Slide 3: Highlights, Financials, Outlook, Q&A, Annex
1 Highlights Q1 2025 2 Financials Q1 2025 3 Outlook 4 Q&A 5 Annex 3
Slide 4: Highlights Q1 2025
Highlights Q1 2025 Gross profit Operating EBITA Free cash flow Cash earnings per share EUR 325 million EUR 142 million EUR 102 million EUR 1.55 +10% on a constant +12% on a constant Q1 2024: EUR 106 Q1 2024: EUR 1.41 currency basis currency basis million 4
Slide 5: Financials
Highlights Financials Outlook Q&A Annex Q1 2025 Q1 2025
Slide 6: Financials Q1 2025 – key figures
Financials Q1 2025 – key figures Fx. adj. EUR million Q1 2025 Q1 2024 Change Change % change Revenue 1,260 1,160 100 9% 9% Gross profit 325 295 30 10% 10% Gross profit as a % of revenue 25.8% 25.4% 0.4% Operating EBITA 142 127 15 12% 12% Operating EBITA as a % of revenue 11.3% 10.9% 0.4% Conversion
Slide 7: Financials Q1 2025 – segment information
Financials Q1 2025 – segment information Asia Holding EUR million EMEA Americas Pacific companies Total Gross profit Q1 2025 149 101 75 325 Q1 2024 144 86 66 295 organic growth 2% 10% 7% 6% acquisition growth 2% 9% 7% 5% currency impact 0% (1%) 0% (0%) Operating EBITA Q1 2025 64 45 42 (10) 142 Q1 20
Slide 8: Financials Q1 2025 – Free cash flow
Financials Q1 2025 – Free cash flow EUR million Q1 2025 Q1 2024 Change Operating EBITA 142 127 15 Depreciation 10 10 - Operating EBITDA 152 136 16 Share based payments 1 1 - IAS 17 lease payments (9) (8) (1) Adjusted Operating EBITDA 145 130 15 Capex (2) (4) 2 ∆ Working capital1 (41) (20) (21) Free
Slide 9: Financials Q1 2025 – net debt
Financials Q1 2025 – net debt 31 March 31 December 31 March EUR million 2025 2024 2024 Reported Net Debt 1,228 1,282 1,443 Reported leverage ratio: Reported (incl. full-year impact of acquisitions) 2.1 2.2 2.7 Leverage ratio based on loan documentation Actual based on loan documentation 2.0 2.1 2.5
Slide 10: Outlook
Highlights Financials Outlook Q&A Annex Q1 2025 Q1 2025
Slide 11: Outlook
Outlook IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Results can be influ
Slide 12: Q&A
Highlights Financials Outlook Q&A Annex Q1 2025 Q1 2025
Slide 13: Annex
Highlights Financials Outlook Q&A Annex Q1 2025 Q1 2025
Slide 14: We are IMCD
We are IMCD IMCD is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. ● Adaptable business model driving simplification for our partners ● Formulatory and solutions provider ● Comprehensive and complementary specialty portfolio ● Global footprint
Slide 15: 8 Business Groups focusing on strategic market segments
8 Business Groups focusing on strategic market segments Pharmaceuticals Coatings & Construction Food & Nutrition Advanced Materials Excipients; APIs; Coatings; decorative paints; Dairy; savoury; bakery; Compounders; converters; nutraceuticals; synthesis; adhesives & sealants; textile & beverage; ani
Slide 16: High scores on external ESG ratings
High scores on external ESG ratings Demonstrating our continuous focus on best practices Score B (2024) Gold (2024) Score B (2023) Gold (2023) On a scale of A to D- ESG Risk Rating 12.6, low risk (2024) C+ (Prime) rating 13.7 (2023) C rating (2023) On a scale of A+ to D- 16
Slide 17: Disclaimer
Disclaimer This presentation may contain forward looking statements. These statements are based on current expectations, estimates and projections of IMCD’s management and information currently available to the company. IMCD cautions that such statements contain elements of risk and uncertainties th